Creatine Monohydrate


Endogenous metabolite / ergogenic supplement

A nitrogenous organic acid; the most thoroughly studied ergogenic supplement; phosphocreatine pool expansion supports rapid ATP regeneration during high-intensity exercise.

Abstract

Creatine monohydrate (N-(aminoiminomethyl)-N-methylglycine; CAS 6020-87-7; molecular formula C4H9N3O2 (anhydrous); molecular weight 131.13) is a nitrogenous organic acid biosynthesized in the liver and kidneys from arginine, glycine, and methionine and stored in skeletal muscle (95 percent of body creatine pool). Mechanism: phosphocreatine, the phosphorylated storage form, donates phosphate to ADP via creatine kinase to rapidly regenerate ATP during high-intensity exercise; supplementation expands the muscle phosphocreatine pool by approximately 20 to 40 percent, supporting longer high-intensity efforts. The most thoroughly studied ergogenic supplement, with hundreds of trials demonstrating consistent ~5 to 10 percent improvement in strength and power output and meaningful effects on lean body mass. Emerging interest in cognitive enhancement, neurodegenerative disease (creatine kinase activity in brain), and depression. Plasma half-life is approximately 3 hours; muscle storage is the relevant pharmacokinetic measure. Used as the canonical ergogenic supplement in sport science and exercise physiology research.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph